arrow_back Back to App

Home Infusion Access: Medicare to Cover Pumps and Drugs

This act expands Medicare coverage to include external infusion pumps and non-self-administrable home infusion drugs. This means individuals requiring regular infusions can receive treatment in their own homes, potentially improving comfort and access to care. Patients will also be informed about the cost-sharing for home treatment compared to other options.
Key points
Medicare will cover external infusion pumps and associated home infusion drugs that require professional supervision.
Home treatment will be available for drugs administered intravenously or subcutaneously at least 12 times per year, or requiring an external infusion pump.
Patients will be notified of cost-sharing differences between home infusion therapy and other care settings.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4993
Sponsor: Rep. Fitzpatrick, Brian K. [R-PA-1]
Process start date: 2025-08-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Joe Fiandra Access to Home Infusion Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4993.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-08-19.

What are the main provisions?

Key points include:

  • Medicare will cover external infusion pumps and associated home infusion drugs that require professional supervision.
  • Home treatment will be available for drugs administered intravenously or subcutaneously at least 12 times per year, or requiring an external infusion pump.
  • Patients will be notified of cost-sharing differences between home infusion therapy and other care settings.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Fitzpatrick, Brian K. [R-PA-1].

What is the latest detailed status?

The latest detailed status is: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Benefits